HIV-associated cognitive impairment before and after the advent of combination therapy

References

• Beck AT, Erbaugh J, Ward CH, Mock J, Mendelsohn M (1961). An inventory for measuring depression. Arch Gen Psycho] 4: 561–571.
   Google Scholar
• Benton AL (1955). The visual retention test. The Psycho-logical Corporation: New York.
   Google Scholar
• Bouwman FH, Skolasky RL, Hes D, Seines OA, Glass JD, Nance-Spros on TE, Royal W, Dal Pan GJM, McArthur JC (1998). Variable progression of HIV-associated demen-tia. Neurology 50: 1814–1820.
   PubMed Web of Science ®Google Scholar
• Bozette SA, Berry SH, Duan N, Frankel MR, Leibowitz AA, Lefkowitz D, Emmons CA, Senterfitt JW, Berk ML, Morton SC, Shapiro MF (1998). The care of HIV-infected adults in the United States. HIV Cost and Services Uti-lization Study Consortium. N Engl I Med 339: 1897–1904.
   Google Scholar
• Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB (1997). Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 11: 1731–1738.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (1996). HIV/AIDS surveillance report. US Department of Health and Human Services Public Health Service: Atlanta, GA.
   Google Scholar
• Chang L, Ernst T, Leonido-Yee M, Will M, Speck O, Walot I, Miller EN (1999). Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV de-mentia. Neurology 53: 782–789.
   PubMed Web of Science ®Google Scholar
• Childs EA, Lyles RH, Selnes OA, Chen B, Miller EN, Cohen BA, Backer JT, Mellors J, McArthur JC (1999). Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 52: 607–613.
   PubMed Web of Science ®Google Scholar
• Concha M, Selnes OA, McArthur JC, Nance-Sproson T, Updike ML, Royal W III, Solomon L, Vlahov D (1995). Normative data for a brief neuropsychologic test battery in a cohort of injecting drug users. Intl J Addictions 30: 823–841.
   Google Scholar
• The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders (1996). Clinical confirma-tion of the American Academy of Neurology algo-rithm for HIV-1 associated cognitive/motor disorder. Neurology 47: 1247–1253.
   Google Scholar
• Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, Abramson I, Atkinson JH, Grant I, McCutchan JA, The HIV Neurobehavioral Research Center Group (1997). Cerebrospinal fluid human immundeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol 42: 679–688.
   PubMed Web of Science ®Google Scholar
• Fahn S, Jenner P, Marsden C, Teykhenne P (1987). Re-cent developments in Parkinson's disease. Macmillan Healthcare Information: Old Tappan, NJ, p 153.
   Google Scholar
• Fatkenheuer G, Theisen A, Rockstroh J, Grabow T, Wicke C, Becker K, Wieland U, Pfister H, Reiser M, Hegener P, Franzen C, Schwenk A, Salzberger B (1977). Virolog-ical treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. AIDS 11: F113–F116.
   Google Scholar
• Flowers KA, Robertson C. (1985). The effects of Parkinson's disease on the ability to maintain a mental set. J Neurol Neurosurg Psychiatry 48: 517–529.
   PubMed Web of Science ®Google Scholar
• Janssen RS, Cornblath DR, Epstein GL, Foa RP, McArthur JC, Price RW (1991). Nomenclature and research case definitions for neurological manifestations of human im-munodeficiency virus type-1 (HIV-1) infection: Report of a Working Group of the American Academy of Neuro-logy AIDS Task Force. Neurology 41: 778–785.
   PubMedGoogle Scholar
• Karnofsky DA, Abelman WH, Craver LF, Burchenal JH (1948). The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1: 634–656.
   Web of Science ®Google Scholar
• Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MVV (1963). Studies of illness in the aged: The index of ADL. JAMA 183: 914–919.
   Google Scholar
• Klove H (1963). Clinical neuropsychology. Med Clin North Am 46: 1647–1658.
   Google Scholar
• Lawton MP, Brody EM (1969). Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist 9: 179–186.
   PubMed Web of Science ®Google Scholar
• McArthur JC, Hoover DR, Bacellar, Miller EN, Cohen BA, Becker JT, Graham NMH, McArthur JH, Seines OA, Jacobson LP, Visscher BR, Concha M, Saah A (1993). Dementia in AIDS patients: Incidence and risk factors. Neurology 43: 2245–2252.
   PubMed Web of Science ®Google Scholar
• McArthur JC, McClernon DR, Cronin MF, Nance-Sproson TE, Saah AJ, St Clair M, Lanier ER (1997). Relationship between human immunodeficiency virus-associated de-mentia and viral load in cerebrospinal fluid and brain. Ann Neurol 42: 689–698.
   PubMed Web of Science ®Google Scholar
• Miller EN, Satz P, Visscher B (1991). Computerized and conventional neuropsychological assessment of HIV-1 infected homosexual men. Neurology 41: 1608–1616.
   PubMed Web of Science ®Google Scholar
• Nelson HE (1982). The National Adult Reading Test (NART): Test manual. The National Hospital for Nervous Diseases: London.
   Google Scholar
• Nelson HE, O'Connell A. (1978). Dementia: The estima-tion of premorbid intelligence levels using the National Adult Reading Test. Cortex 14: 234–244.
   PubMed Web of Science ®Google Scholar
• Price RW, Brew BJ (1988). The AIDS dementia complex. J Infect Dis 158: 1079–1083.
   PubMed Web of Science ®Google Scholar
• Radloff LL (1977). The CES-D: A self-report depression scale for research in the general population. Appl Psycho] Meas 1: 385–401.
   Web of Science ®Google Scholar
• Reitan R (1958). Validity of the Trail Making test as an in-dicator of organic brain damage. Percept Motor Skills 8: 271–276.
   Google Scholar
• Reitan R (1979). Manual for administration of neu-ropsychologica 1 test batteries for adults and children. Neuropsychologial Laboratory: Tucson, AZ.
   Google Scholar
• Rey A (1941). L'examen psychological dans les cas d'encephalopathie traumatique. Arch Psycho] 28: 286–340.
   Google Scholar
• Sacktor NC, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC, The Multi-center AIDS Cohort Study (1999). HIV-1-related neuro-logical disease incidence changes in the era of highly active antiretroviral therapy. Neurology 52: A252–253.
   Web of Science ®Google Scholar
• Sacktor NC, Skolasky RL, Lyles RH, Esposito D, Selnes OA, McArthur JC (2000a). Improvement in HIV-associated motor slowing after antiretroviral therapy including pro-tease inhibitors. J NeuroVirol 6: 84–88.
   Web of Science ®Google Scholar
• Sacktor NC, Pomper MG, Ilorska A, Barker PB, McArthur JC (2000b). Magnetic resonance spectroscopic imag-ing measures metabolite changes during therapy for HIV-associated cognitive impairment. Neurology 54: A252.
   Google Scholar
• Selnes OA, Jacobson L, Machado AM, Becker JT, Wesch J, Miller EN, Visscher B, McArthur JC (1991). Normative data for a brief neuropsychological screening battery. Percept Mot Skills 73: 539–550.
   PubMed Web of Science ®Google Scholar
• Stewart AL, Ware JE (1993). Measuring function and well-being: The Medical Outcomes Study approach. Duke University Press: Durham, NC.
   Google Scholar
• Wechsler D (1981). Wechsler Adult Intelligence Scale—Revised. The Psychological Corporation: New York.
   Google Scholar